Patents by Inventor Wolfgang Prohaska

Wolfgang Prohaska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized leukocytes and their use
    Patent number: 8900864
    Abstract: A method of producing extremely stable leukocytes from human blood samples which are stable for long period of time under extraordinary temperature conditions. The method also relates to producing and stabilizing the leukocytes with formaldehyde release agents. The method is directed at the use of the stabilized leukocytes as a control in assays for determining CD4+ and HIV diagnosis and therapy.
    Type: Grant
    Filed: September 13, 2011
    Date of Patent: December 2, 2014
    Assignee: Nordrhein-Wesfalen Krankenhausbetriebsgesellschaft Bad Oeynhausen mbH
    Inventors: Christian Prante, Knut Kleesiek, Wolfgang Prohaska
  • STABILIZED LEUKOCYTES AND THEIR USE IN HIV-DIAGNOSIS AND THERAPY
    Publication number: 20130183661
    Abstract: A method of producing extremely stable leukocytes from human blood samples which are stable for long period of time under extraordinary temperature conditions. The method also relates to producing and stabilizing the leukocytes with formaldehyde release agents. The method is directed at the use of the stabilized leukocytes as a control in assays for determining CD4+ and HIV diagnosis and therapy.
    Type: Application
    Filed: September 13, 2011
    Publication date: July 18, 2013
    Applicant: HERZ-UND DIABETESZENTRUM NORDRHEIN-WESFALEN KRANKENHAUSBETRIEBSGESELLSCHAFT BAD OEYNHAUSEN MBH
    Inventors: Christian Prante, Knut Kleesiek, Wolfgang Prohaska
  • Mutant of tissue factor pathway inhibitor, DNA sequence and use for detecting thrombotic disorders
    Patent number: 6521410
    Abstract: The invention relates to a novel mutant of tissue factor pathway inhibitor (TFPI) protein and its corresponding DNA sequence. The mutant can be found in humans who show or may show an increased risk of thrombotic diseases. By screening samples of human blood for said DNA or fragments of it, it is possible to predict a disposition of thrombotic disorders by which prophylactic application or measures can be initiated.
    Type: Grant
    Filed: June 9, 2001
    Date of Patent: February 18, 2003
    Inventors: Thomas Brinkmann, Wolfgang Prohaska, Christian Goetting, Michael Schmidt